Association between race/ethnicity and the risk of amputation of lower extremities among medicare beneficiaries with diabetic foot ulcers and diabetic foot infections.

INTRODUCTION: This study aimed to examine the association of race and ethnicity on the risk of lower extremity amputations among Medicare beneficiaries with diabetic foot ulcers (DFUs) and diabetic foot infections (DFIs). RESEARCH DESIGN AND METHODS: A retrospective study included 2011-2015 data of a 5% sample of fee-for-service Medicare beneficiaries with a newly diagnosed DFU and/or DFI. The primary outcome was the time to the first major amputation episode after a DFU and/or DFI were identified using the diagnosis and procedure codes. We used multivariable Cox proportional hazards models to estimate the risk of time to the first major amputation across races, adjusting for sociodemographic and health status factors. Adjusted hazard ratios (aHRs) with a 95% CI were reported.
RESULTS: Among 92 929 Medicare beneficiaries newly diagnosed with DFUs and/or DFIs, 77% were whites, 14.3% African Americans (AAs), 3.3% Hispanics, 0.7% Native Americans (NAs), and 4.0% were other races. The incidence rates of major amputation were 0.02 person-years for NAs, 0.02 person-years for AAs, 0.01 person-years for Hispanics, 0.01 person-years for other races, and 0.01 person-years for whites (p<0.05). Multivariable analysis showed that AAs (aHR=1.9, 95% CI 1.7 to 2.2, p<0.0001) and NAs (aHR=1.8, 95% CI 1.3 to 2.6, p=0.001) were associated with an increased risk of major amputation compared with whites. Beneficiaries with DFUs and/or DFIs diagnosed by a podiatrist or primary care physician (aHR=0.7, 95% CI 0.6 to 0.8, p<0.0001, specialists as reference) or at an outpatient visit (aHR=0.3, 95% CI 0.3 to 0.3, p<0.0001, inpatient stay as reference) were associated with a decreased risk of major amputation.
CONCLUSIONS: Racial and ethnic disparities in the risk of lower extremity amputations appear to exist among fee-for-service Medicare beneficiaries with diabetic foot problems. AAs and NAs with DFUs and/or DFIs were associated with an increased risk of major amputations compared with white Medicare beneficiaries. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

The prevalence and incidence of diabetic foot ulcerations, peripheral artery disease, and lower extremity amputation differ by race and ethnicity. Although the relationship between race/ethnicity and the risk of peripheral arterial disease and amputation is well studied, there is conflicting evidence on the association of race/ethnicity and the risk of diabetes-related amputations.

Racial and ethnic disparities in diabetes-related amputation and access to care exist among fee-for-service Medicare beneficiaries.

Adjusting for socioeconomic factors and pre-existing medical comorbidities, African Americans and Native Americans experienced 1.8–1.9 times higher risk of major amputation for diabetic foot ulcerations and/or diabetic foot infections than White Medicare beneficiaries.

There were no significant difference in the risk of diabetes-related amputation for Hispanics and Whites.

Race/ethnicity, the severity of presentation (including foot infection), and the location of the initial care of the diabetic foot problems independently affect the risk of major amputation.

An improved access to a primary care physician or podiatrist to care for foot ulcers could help address the disparities for diabetes-related amputation among the racial/ethnic minorities.

Introduction

Diabetes has become one of the fastest growing chronic diseases diagnosed in the USA, affecting approximately 24.7 million people (9.7% of adults) as of 2017.1 It is estimated that more than one-third of the US population will have diabetes by 2050, and 34% of those will develop a diabetic foot ulcer (DFU) at some point in their lifetime.2 3 Foot ulceration is a lifelong problem for patients with diabetes. On average, two-thirds of DFUs take more than 1 year to heal, and the recurrence rate is estimated to be as high as 65% over 5 years.3 4 In 2010, lower extremity amputations among patients with diabetes accounted for 60% of non-traumatic amputations in the USA.5 DFUs and diabetic foot infections (DFIs) are the leading causes of amputations. Mortality rates, physical function, and quality of life are significantly worse in patients with DFUs/DFIs and after amputations.6–10

The prevalence and incidence of diabetes, DFUs, DFIs, and amputations differ by race and ethnicity.11 12 African Americans (AAs), Hispanics, and Native Americans (NAs) have a higher prevalence of diabetes than non-Hispanic whites (hereafter referred to as “whites”).11 12 Consequently, the incidence of DFUs and amputations are disproportionately higher in AAs, Hispanics, and NAs.12 In 2008, the incidence of DFUs among Medicare beneficiaries was 6.0% for whites, 6.3% for AAs, 6.4% for Hispanics, and 7.0% for NAs.11 The incidence of diabetes-related amputations in AAs and other minorities was more than double that of whites.11

Health disparities or health inequities have been well documented for diabetes, peripheral arterial disease (PAD), and amputations.13–15 More specifically, the relationship between race/ethnicity and PAD and amputation has been well studied and confirmed through consistent findings, but there is conflicting evidence on the effect of race/ethnicity on diabetes related amputations.16 While a few studies found approximately a 1.5–2.0-fold increased risk of amputation among AAs and Hispanics with diabetes,17–20 other studies did not find any differences in the risk of amputation between whites and minority races.21 22 Additionally, socioeconomic and insurance statuses are the main contributors to the elevated risk of amputation among racial and ethnic minorities.23–26 However, the majority of previous studies evaluating disparities in amputation among patients with diabetes did not adjust for socioeconomic background or insurance status. Hence, we sought to examine the association between race/ethnicity (whites, AAs, Hispanics, NAs, and other races) and the risk of amputation of lower extremities among Medicare beneficiaries with DFUs and/or DFIs.

Methods

Data sources

This study used Medicare administrative claims data of a 5% national representative sample from 2011 to 2015 (approximately 3.6 million unique beneficiaries). Medicare is the US governmental health insurance program provided to individuals aged ≥65 years and those aged <65 years with certain disabilities or end-stage renal diseases (ESRDs).27 The data files included master beneficiary summary files (MBSF) with enrollment and eligibility information; claims for inpatient, outpatient, and professional services as well as skilled nursing facilities; and Part D Events files. The University of Arizona Institutional Review Board approved this study.

Study design and cohort

This retrospective cohort study included fee-for-service beneficiaries with diabetes and a newly diagnosed DFU and/or DFI from 2011 to 2014 using the International Classification of Diseases codes (see online supplementary table 1 for International classification of diseases, 9th revision, clinical modification (ICD-9-CM)/ICD-10-CM codes).28 We restricted the analytical sample to beneficiaries with at least one medical claim with a diabetes diagnosis, and at least one medical claim with a DFU and/or DFI diagnosis. DFU and DFI include ulcer of lower limbs, ulcer of the heel and midfoot, ulcer of other parts of the foot, chronic ulcer of other specified sites, chronic ulcer of unspecified sites, osteomyelitis, cellulitis and abscess of the toe, cellulitis and abscess of the foot (except toes), gangrene, or gas gangrene. The method has been used and verified by other studies.28 29 The index date was the earliest date of the patient’s diagnosis of a DFU and/or DFI during the study period.

We excluded beneficiaries who (1) were non-US residents; (2) received hospice services during the study period (table 1); and, (3) did not have continuous enrollment in Parts A, B, and D for at least 6 months before the index date or the index date was after 1/1/2015 (figure 1). Each beneficiary was followed up until one of the following events: a major amputation for lower extremity, death, enrollment into Medicare Advantage plans, or the end of the study period (12/31/2015).

Table 1

Characteristics of the study population stratified by amputation status

	Total(n=92 929)	No amputation(n=91 203)	Major amputation(n=1726)	P value
Demographics
Age, mean (SD)	71.87 (11.86)	71.96 (11.85)	67.06 (12.51)	<0.0001
Age group
<65 years	23 212 (24.98)	22 477 (24.65)	735 (42.58)	<0.0001
≥65 years	69 717 (75.02)	68 726 (75.35)	991 (57.42)
Gender
Male	42 508 (45.74)	41 423 (45.42)	1085 (62.86)	<0.0001
Female	50 421 (54.26)	49 780 (54.58)	641 (37.14)
Socioeconomic factors
Disability	28 683 (30.87)	27 814 (30.50)	869 (50.35)	<0.0001
Low income subsidy	59 063 (63.56)	57 802 (63.38)	1261 (73.06)	<0.0001
Country residence
Metropolitan	76 248 (82.05)	74 958 (82.19)	1290 (74.74)	<0.0001
Non-metropolitan	16 534 (17.79)	16 100 (17.65)	434 (25.14)
Unknown	147 (0.16)	145 (0.16)	2 (1.36)
Median income
Q1	23 353 (25.13)	22 767 (24.96)	586 (33.95)	<0.0001
Q2	23 343 (25.12)	22 872 (25.08)	471 (27.29)
Q3	23 063 (24.82)	22 688 (24.88)	375 (21.73)
Q4	23 170 (24.93)	22 876 (25.08)	294 (17.03)
Poverty
<20%	73 137 (78.70)	71 889 (78.82)	1248 (72.31)	<0.0001
≥20%	19 792 (21.30)	19 314 (21.18)	478 (27.69)
Medical history
ESRD	2448 (2.63)	2192 (2.40)	256 (14.83)	<0.0001
PAD	49 774 (53.56)	48 307 (52.97)	1467 (84.99)	<0.0001
Insulin	14 672 (15.79)	14 131 (15.49)	541 (31.34)	<0.0001
Elixhauser comorbidity index, mean (SD) (range 0–29)	3.87 (2.88)	3.85 (2.87)	4.98 (3.35)	<0.0001
DCSI, mean (SD) (range 0–13)	2.12 (1.35)	2.11 (1.35)	3.06 (1.39)	<0.0001
Index diagnosis
DFU	29 696 (31.96)	28 930 (31.72)	766 (44.38)	<0.0001
DFI	63 233 (68.04)	62 273 (68.28)	960 (55.62)	<0.0001
Specialty for DFU/DFI diagnosis
Primary care	10 806 (11.63)	10 681 (11.71)	125 (7.24)	<0.0001
Podiatry	20 625 (22.19)	20 439 (22.41)	186 (10.78)
Specialist	61 498 (66.18)	60 083 (65.88)	1415 (81.98)
Place of DFU/DFI diagnosis
Hospital	6814 (7.33)	6350 (6.96)	464 (26.88)	<0.0001
Outpatient	49 979 (53.78)	49 329 (54.09)	650 (37.66)
ED	1845 (1.99)	1757 (1.93)	88 (5.10)
Home health agency	606 (0.65)	598 (0.66)	8 (0.46)
Skilled nursing facility	3546 (3.82)	3479 (3.81)	67 (3.88)
Other	30 139 (32.43)	29 690 (32.55)	449 (26.01)
Early PCP follow-up (30 days after diagnosis)	45 727 (49.21)	44 639 (48.94)	1088 (63.04)	<0.0001
Revascularization within 12 months	8178 (8.80)	7288 (7.99)	890 (51.56)	<0.0001
Healthcare utilization after diagnosis
ED visits per person, mean (SD)	0.63 (1.36)	0.63 (1.35)	1.09 (1.73)	<0.0001
Outpatient visits per person, mean (SD)	3.19 (5.91)	3.22 (5.93)	1.14 (4.45)	<0.0001
Inpatient hospital stay per person, mean (SD)	16.06 (29.84)	15.70 (29.50)	35.08 (44.16)	<0.0001

Values are reported as number (%) unless otherwise specified.

DCSI, Diabetes Complications Severity Index; DFI, diabetic foot infection; DFU, diabetic foot ulcer; ED, emergency room; ESRD, end-stage renal disease; PAD, peripheral artery disease; PCP, primary care physician; Q, quartile.

Figure 1

Flowchart of the study population.

Primary outcome: time to first major amputation for lower extremities

Our primary outcome was time to the first major amputation episode for lower extremities, including both above-knee amputation (AKA) and below-knee amputation (BKA) after the index diagnosis of a DFU or DFI. We used the ICD-9 Procedure codes and the Current Procedure Terminology codes to identify AKA (V49.76, 27 590–27 592, 27 596, and 27 598) and BKA (V49.75, 27 880–27 882, 27 886, 27 888, and 27 889).

Main independent variable and covariates

Based on the race/ethnicity information in the MBSF dataset, we categorized beneficiaries into five racial/ethnic groups (ie, our main independent variable): whites, AAs, Hispanics, NAs, and other races (including Asians and other or unknown races).

We also considered several sociodemographic and health status covariates in the analyses. Sociodemographic factors included age, gender (male vs female), disability status, receipt of low-income subsidy, and type of resided county (metropolitan, non-metropolitan, and unknown). We linked the data to the Area Health Resources Files to obtain information on median household income (divided into quartiles), and percentage of individuals residing below the federal poverty level at the specific residential area (<20% vs ≥20%) based on the individual’s resided zip code.

Several health status covariates measured in the 6 months prior to the index DFU/DFI diagnosis included ESRD, PAD, receiving insulin therapy, the Elixhauser comorbidity index (range 0–29, excluding diabetes categories), and the Diabetes Complication Severity Index (DCSI) (range 0–13).30–32

We also included the specialty of the provider (primary care physician (PCP), podiatry, and specialist) and type of service settings (inpatient, outpatient, emergency department (ED), home health agency, skilled nursing facility, and others) regarding the initial DFU and/or DFI diagnosis.14 The utilization of healthcare resources included a PCP follow-up visit 30 days after the index diagnosis, open surgery or a percutaneous procedure for revascularization of lower extremities within a year after the diagnosis of DFU and/or DFI, number of ED visits within a year (per person), outpatient visits within a year (per person), and inpatient hospital stay per person (average within a year) after the index diagnosis.14

Statistical analysis

The characteristics of beneficiaries with DFUs/DFIs in each racial group are described as a mean and SD, or a median and IQR, for continuous variables as well as a frequency and a percentage for categorical variables. The analysis of variance and χ² test were used to compare continuous and categorical variables among the racial/ethnic groups, respectively. We used Kaplan-Meier (KM) survival curves to describe the time to first major amputations across racial groups during the study period. Multivariable Cox proportional hazard models were performed to estimate the risk of major amputation for lower extremities across racial/ethnic groups, adjusting for the covariates described above. The adjusted hazard ratio (aHR) with a 95% CI was reported. P<0.05 (two-tailed) was considered as statistically significant in the study. All the analyses were performed using SAS V.9.4 (SAS, Cary, North Carolina, USA).

Results

Among the 92 929 Medicare beneficiaries with a DFU/DFI, 72 219 (77.7%) were whites, 13 279 (14.3%) were AAs, 3039 (3.3%) were Hispanics, 611 (0.7%) were NAs, and 3781 (4.0%) were other races. The median follow-up for the study cohort was 911 days (IQR=650 days). During the study period, 1726 beneficiaries (1.9%) underwent a major amputation.

As shown in table 1, compared with beneficiaries with DFUs/DFIs who did not have a major amputation, those who did have a major amputation for lower extremities during the study period were more likely to be younger (<65 years: 42.6% vs 24.7%), male (62.9% vs 45.4%), have ESRD (14.8% vs 2.4%), PAD (85.0% vs 53.0%), and more severe diabetes-related complications as determined by the DCSI (3.06 vs 2.11), and use insulin (31.3% vs 15.5%). Those who had a major amputation were also more likely to have a disability (59.4% vs 30.5%), receive a low-income subsidy (73.1% vs 63.4%), live in non-metropolitan area (25.1% vs 17.7%), and live in areas with more than a 20% poverty level (27.7% vs 21.2%). In addition, they were more likely to be seen by a specialist at the initial diagnosis (82.0% vs 65.9%), but less likely to be seen by a PCP (7.2% vs 11.7%) or a podiatrist (10.8% vs 22.4%). Compared with those who did not have a major amputation, those who did had significantly more ED visits per person (mean=1.1 ± 1.7 visits vs 0.6±1.4 visits), longer inpatient stay per person (44.2 days vs 29.5 days), and fewer outpatient visits (4.5 visits vs 5.9 visits) within a year after the diagnosis of a DFU and/or DFI.

Unadjusted association between racial groups and risk of major amputation for lower extremities

In unadjusted analyses (table 2), compared with white beneficiaries, the risks of major amputation for lower extremities were significantly higher for NAs (HR=3.62, 95% CI=2.53 to 5.17, p<0.0001), AAs (HR=2.65, 95% CI=2.38 to 2.94, p<0.0001), and Hispanic (HR=1.41, 95% CI=1.10 to 1.82, p=0.0007) beneficiaries. As shown in figure 2, the unadjusted KM survival analysis demonstrated that the percentages of major amputation events were higher for NAs (5.1%), AAs (3.8%), Hispanics (2.1%), and Others (1.5%) than whites with DFUs/DFIs (1.5%). Minority beneficiaries, including Hispanics (89.5%), others (86.9%), and AAs (85.2%), were more likely than whites were (81.0%, p<0.0001) to have a DFI as an index diagnosis.

Table 2

Characteristics of study population stratified by racial and ethnic groups

	White(n=72 219)	African American(n=13 279)	Hispanic(n=3039)	Native American(n=611)	Other(n=3781)
Demographics
Age, mean (SD)	72.6 (11.5)	68.6 (12.8)	69.7 (14.1)	66.6 (12.4)	71.7 (11.4)
Age group
<65 years	16 140 (22.4)	4907 (37.0)	992 (32.6)	250 (40.9)	923 (24.4)
≥65 years	56 079 (77.7)	8372 (63.1)	3264 (67.4)	361 (59.1)	2858 (75.6)
Gender
Male	33 673 (46.6)	5310 (40.0)	1386 (45.6)	269 (44.0)	1870 (49.5)
Female	38 546 (53.4)	7969 (60.0)	1653 (54.4)	342 (56.0)	1911 (50.5)
Socioeconomic factor
Disability	20 204 (28.0)	6188 (46.6)	1155 (38.0)	313 (51.2)	823 (21.8)
Low income subsidy	42 543 (58.9)	10 377 (78.2)	2741 (90.2)	506 (82.8)	2896 (76.6)
Country residence
Metropolitan	57 807 (80.0)	11 717 (88.2)	2840 (93.5)	298 (48.8)	3586 (94.8)
Non-metropolitan	14 312 (19.8)	1542 (11.6)	188 (6.2)	309 (50.9)	183 (4.9)
Unknown	100 (0.1)	20 (0.2)	11 (0.4)	4 (0.7)	12 (0.3)
Median income
Q1	17 480 (24.2)	4267 (32.1)	996 (32.8)	287 (47.0)	323 (8.5)
Q2	18 744 (26.0)	3279 (24.7)	472 (15.5)	180 (29.5)	668 (17.7)
Q3	17 481 (24.2)	3142 (23.7)	985 (32.4)	80 (13.1)	1375 (36.4)
Q4	18 514 (25.6)	2591 (19.5)	586 (19.3)	64 (10.5)	1415 (37.4)
Poverty
<20%	58 894 (81.6)	8752 (65.9)	1891 (62.2)	349 (57.1)	3251 (86.0)
≥20%	13 325 (18.5)	4527 (34.1)	1148 (37.8)	262 (42.9)	530 (14.0)
Low income subsidy	42 543 (58.9)	10 377 (78.2)	2741 (90.2)	506 (82.8)	2896 (76.6)
Medical history
ESRD	1191 (1.7)	843 (6.4)	177 (5.8)	61 (10)	176 (4.7)
PAD	38 105 (52.8)	7943 (59.8)	1658 (54.6)	352 (57.6)	1716 (45.4)
Insulin	10 328 (14.3)	2835 (21.4)	738 (24.3)	157 (25.7)	614 (16.2)
Elixhauser comorbidity index, mean (SD) (range 0–29)	3.8 (2.8)	4.4 (3.2)	3.9 (2.8)	4.0 (3.0)	3.5 (2.7)
DCSI, mean (SD) (range 0–13)	2.1 (1.3)	2.4 (1.4)	2.3 (1.4)	2.2 (1.5)	2.1 (1.3)
Index diagnosis
DFU	13 726 (19.0)	1963 (14.8)	319 (10.5)	119 (19.5)	496 (13.1)
DFI	58 493 (81.0)	11 316 (85.2)	2720 (89.5)	492 (80.5)	3285 (86.9)
Specialty for DFU/DFI diagnosis
Primary care	8367 (11.6)	1406 (10.6)	389 (12.8)	95 (15.6)	549 (14.5)
Podiatry	16 405 (22.7)	2748 (20.7)	628 (20.7)	69 (11.3)	775 (20.5)
Specialist	47 447 (65.7)	9125 (68.7)	2022 (66.5)	447 (73.2)	2457 (65)
Place of DFU/DFI diagnosis
Hospital	4098 (5.7)	1041 (7.8)	174 (5.7)	57 (9.3)	172 (4.6)
Outpatient	10 632 (14.7)	1797 (13.5)	328 (10.8)	253 (41.4)	370 (9.8)
ED	809 (1.1)	213 (1.6)	44 (1.5)	17 (2.8)	42 (1.1)
Home health agency	476 (0.7)	85 (0.6)	26 (0.9)	1 (0.2)	18 (0.5)
Skilled nursing facility	1628 (2.3)	363 (2.7)	51 (1.7)	8 (1.3)	82 (2.2)
Other	54 576 (75.6)	9780 (73.7)	2416 (79.5)	275 (45.0)	3097 (81.9)
Early PCP follow-up (30 days after diagnosis)	35 242 (48.8)	6742 (50.8)	1523 (50.1)	328 (53.7)	1892 (50.0)
Revascularization within 12 months	5499 (7.6)	1899 (14.3)	345 (11.4)	101 (16.5)	334 (8.8)
Healthcare utilization after DFU/DFI diagnosis
ED visits per person, mean (SD)	0.02 (0.2)	0.03 (0.2)	0.03 (0.2)	0.03 (0.2)	0.01 (0.1)
Outpatient visits per person, mean (SD)	1.59	2.25	2.39	2.23	1
Inpatient hospital stay per person, mean (SD)	13.93 (27.6)	19.26 (28.7)	15.4 (21.6)	15.65 (26.95)	15.65 (27.0)
Number of major amputations	1068 (1.5)	507 (3.8)	64 (2.1)	31 (5.1)	56 (1.5)
Unadjusted risks of major amputation	Reference	HR=2.65, 95% CI=2.38 to 2.94, p<0.0001	HR=1.41, 95% CI=1.10 to 1.82, p=0.0007	HR=3.62, 95% CI=2.53 to 5.17, p<0.0001	HR-1.00, 95% CI=0.77 to 1.31, p=0.98

Values are reported as number (%) unless otherwise specified.

DCSI, Diabetes Complications Severity Index; DFI, diabetic foot infection; DFU, diabetic foot ulcer; ED, emergency room; ESRD, end-stage renal disease; PAD, peripheral artery disease; PCP, primary care physician; Q, quartile.

Figure 2

Kaplan-Meier survival curve for major amputation (online supplementary table 1). ICD-9-CM codes. DFI, diabetic foot infection; DFU, diabetic foot ulcer; ICD-CM, International classification of diseases, 9th revision, clinical modification.

Adjusted association of race and ethnicity with major amputation for lower extremities

In multivariable analyses (table 3), the risk of major amputation was significantly higher for AAs (aHR=1.92, 95%=CI 1.71 to 2.15, p≤0.0001) and NAs (aHR=1.81, 95% CI=1.26 to 2.61, p=0.001) compared with white beneficiaries. There was no difference in the risk of major amputation for lower extremities between Hispanics (aHR=1.18, 95% CI=0.88 to 1.60, p=0.27) and other races (aHR 1.18, 95% CI 0.86 to 1.60, p=0.31) compared with white beneficiaries with DFUs/DFIs.

Table 3

Cox proportional hazard models for major amputation

	Adjusted HR	95% CI	P value
Race/Ethnicity
White	Reference
African American	1.92	1.71 to 2.15	<0.0001
Hispanic	1.09	0.84 to 1.41	0.6
Native American	1.81	1.26 to 2.61	0.001
Other	1.02	0.78 to 1.34	0.88
Age	1.01	0.99 to 1.01	0.33
Male gender	1.79	1.62 to 1.98	<0.0001
Disability	1.31	1.16 to 1.47	<0.0001
County residence
Metropolitan	Reference
Non-metropolitan	1.4	1.23 to 1.58	<0.0001
Median income
Q1	Reference
Q2	0.88	0.76 to 1.03	0.11
Q3	0.75	0.63 to 0.90	0.001
Q4	0.69	0.57 to 0.83	0.0001
Poverty
<20%	Reference
≥20%	0.89	0.76 to 1.03	0.1
Low income subsidy	1.34	1.19 to 1.51	<0.0001
PAD	2.95	2.55 to 3.41	<0.0001
ESRD	2.77	2.36 to 3.22	<0.0001
Elixhauser Comorbidity Index	1.01	0.99 to 1.02	0.64
DCSI	1.19	1.14 to 1.24	<0.0001
Insulin	1.62	1.45 to 1.81	<0.0001
Specialty for diagnosis
Primary care	Reference
Podiatry	0.89	0.71 to 1.12	0.31
Specialist	1.46	1.20 to 1.76	0.0001
Place of diagnosis
Hospital	Reference
Emergency department	0.85	0.68 to 1.07	0.16
Outpatient	0.3	0.27 to 0.34	<0.0001
Home health agency	0.22	0.11 to 0.45	<0.0001
Skilled nursing facility	0.5	0.38 to 0.66	<0.0001
Others	0.29	0.26 to 0.34	<0.0001

DCSI, Diabetes Complications Severity Index; ESRD, end stage renal disease; PAD, peripheral artery disease; Q, quartile.

Factors associated with major amputation for lower extremities

Factors associated with an increased risk of major amputation for lower extremities included male gender (aHR 1.79, 95% CI 1.62 to 1.98), medical comorbidities that included PAD (aHR 2.95, 95% CI 2.55 to 3.41) and ESRD (aHR 2.77, 95% CI 2.36 to 3.22)], a higher DCSI (aHR 1.19, 95% CI 1.14 to 1.24), and use of insulin (aHR 1.62, 95% CI 1.45 to 1.81) (all p<0.0001).

Disabled individuals (aHR 1.31, 95% CI 1.16 to 1.47), residents of non-metropolitan counties (HR=1.40, 95% CI 1.23 to 1.58), and low-income subsidy recipients (aHR 2.11, 95% CI 1.66 to 2.69) (all p<0.0001) had a significantly higher risk of major amputation. A higher median income was associated with a lower risk of amputation (Q1: reference; Q2: aHR 0.88, 95% CI 0.76 to 1.03, p=0.11; Q3: aHR 0.75, 95% CI 0.63 to 0.90, p=0.001; Q4: aHR 0.69, 95% CI 0.57 to 0.83, p=0.0001).

Beneficiaries whose index DFUs/DFIs were diagnosed by a specialist were associated with an increased risk of major amputation for lower extremities (aHR 1.46, 95% CI 1.20 to 1.76, p=0.0001) than those with index DFUs/DFIs who were diagnosed by a PCP or a podiatrist. When the comparison was made with beneficiaries who had the index diagnosis made during an outpatient visit, the risk of amputation appeared to be higher for patients who had a diagnosis made during an inpatient admission or ED visit.

Discussion

Our retrospective cohort study is one of the largest population-based studies demonstrating that racial/ethnic disparities exist regarding the risk of major amputation for lower extremities among fee-for-service Medicare beneficiaries newly diagnosed with a DFU/DFI. AAs and NAs experienced a higher risk of major amputation compared with white beneficiaries after developing a DFU or DFI. Minorities had more significant medical comorbidities on presentation and were more likely to present with a DFI than whites were. Healthcare resource utilization for DFU/DFI care, including outpatient visits and hospital admissions, was significantly higher for minority than for white beneficiaries.

Compared with white beneficiaries, our adjusted analysis showed a 1.8–1.9 times higher risk of major amputation for DFU/DFI among AAs and NAs, but no significant difference in the risk of major amputation for Hispanics. Although racial disparity in amputation is better documented in PAD, prior studies examining the association of racial/ethnic disparities in amputation for lower extremities in diabetes are inconsistent or inconclusive. A recent study by our group reported a considerably higher risk of major amputations among minorities admitted with DFIs than whites.29 Studies by Lavery et al and Resnick et al also described an increased risk of amputation for AAs compared with whites, while Karter et al reported no difference in the risk of amputation among AAs and whites as well as among AAs and Hispanics.17 18 22 A different study evaluating Medicare beneficiaries with ESRD and diabetes reported that the risk of amputation was highest in whites compared with AA and other minorities.21 The inconsistent findings could be due to different study populations.17 18 21 22 29

Possible explanations for the higher risk of amputation observed in minorities include results shaped by more advanced presentation of a diabetic foot problem, the presence of more severe comorbidities, and the lack of access to limb salvage services. Similar to others, our study suggests minorities at risk of major amputation for lower extremities were more likely to have DFI and PAD on presentation.24 33 In addition, DFI and progressive gangrene are the leading causes of major amputation in patients with diabetes.6 34 35 Insurance status, a surrogate reflecting access to medical care, is one of the most significant contributors of disparities in lower extremity amputation.23 36 Major amputations are more likely to be performed on patients without any, or with suboptimal, health insurance coverage, such as Medicaid.36 37 It is, however, unclear whether the same disparities exist among the insured population with presumably better access to medical care. Our study demonstrates that racial disparity existed and is independently associated with the risk of amputation among Medicare beneficiaries insured by fee-for-service plans, even after adjusting for all the potential sociodemographic and health status confounders.

DFUs and DFIs are associated with significant healthcare utilization.14 In this study, patients who had major amputations required more outpatient visits, ED visits, and hospital admissions compared with those without major amputations. Minority beneficiaries with DFUs/DFIs had significantly higher numbers of outpatient visits, ED visits, and inpatient hospital stays compared with white beneficiaries. Where the patient first presented for care also had a significant implication on the risks for major amputation. Beneficiaries whose DFUs/DFIs were diagnosed by a PCP or podiatrist were associated with a lower risk of amputation than those who were diagnosed by specialists. Similarly, the risk of major amputation for lower extremities was substantially lower when the diagnosis was made in an outpatient setting and not during hospital admission. It is unclear the exact reason for this observation. Potential explanations might be the more severe disease on presentation requiring hospital admission, where patients are more likely to see a specialist and not their primary care providers or podiatrists. It is also possible that the primary care providers were not comfortable with treating diabetic foot problems and patients were sent to see a specialist for diagnosis and treatment.

There are several limitations in our study. First, this is an observational study using administrative claims data. Although we tried to control for potential confounders, we do not have sociobehavioral and clinical information, such as diet and HbA1C level, and we cannot rule out unmeasured confounders. Second, there is a lack of information on the severity of the presentation, including the size of the ulcer, the severity of the infection, as well as the extent of arterial insufficiency. We also do not have information on the history of previously healed ulcers. These factors, including the severity of PAD, are likely important in evaluating major amputation risk. However, we attempted to adjust for diabetes severity as a proxy of disease severity. Third, we relied on the race/ethnicity information documented in the Medicare administrative data, and such information can vary by racial and ethnic groups.38 Fourth, we could not determine insurance status prior to the start of Medicare coverage due to the limitation of the dataset. Finally, the findings derived from the fee-for-service Medicare beneficiaries may not be generalizable to individuals enrolled in Medicare Advantage plans or other populations (eg, government sponsored Medicaid).

AAs and NAs with DFUs and DFIs were associated with an increased risk of major amputation of lower extremities compared with white Medicare beneficiaries. Race/ethnicity, the severity of presentation (including foot infection), and the location of the initial care of the diabetic foot problems independently affect the risk of major amputation. There are racial and ethnic disparities in diabetes-related amputation and access to care for DFUs/DFIs among Medicare beneficiaries. An improve access to a PCP or podiatrist to care for DFUs/DFIs would help to address the disparities for amputation among the racial/ethnic minorities.